Use of remdesivir and/or nirmatrelvir/ritonavir in patients hospitalised for acute SARS-CoV-2 is tied to fewer deaths during the Omicron era, notably in unvaccinated patients without prior infection.
Medscape News UK
Source link : https://www.medscape.com/viewarticle/unvaccinated-may-benefit-most-covid-19-antivirals-2025a1000pom?src=rss
Author :
Publish date : 2025-09-29 12:00:00
Copyright for syndicated content belongs to the linked Source.